BiotechTube

Solriamfetol 150 mg Oral Tablet

Phase 1Completed
0 watching 0 views this week💤 Quiet
30
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Narcolepsy

Conditions

Narcolepsy, Obstructive Sleep Apnea, Excessive Daytime Somnolence, Excessive Sleepiness, Postpartum

Trial Timeline

Aug 27, 2021 → Apr 15, 2022

NCT ID
NCT05008341

About Solriamfetol 150 mg Oral Tablet

Solriamfetol 150 mg Oral Tablet is a phase 1 stage product being developed by Axsome Therapeutics for Narcolepsy. The current trial status is completed. This product is registered under clinical trial identifier NCT05008341. Target conditions include Narcolepsy, Obstructive Sleep Apnea, Excessive Daytime Somnolence.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT05008341Phase 1Completed

Competing Products

20 competing products in Narcolepsy

See all competitors
ProductCompanyStageHype Score
E2086 + E2086 Placebo + Active Comparator + Active Comparator PlaceboEisaiPhase 1
33
MK-6552 + PlaceboMerckPhase 1
33
Sodium Oxybate (Xyrem)UCBPhase 1
30
JZP-110 + PlaceboJazz PharmaceuticalsPhase 2
49
ADX-N05 + PlaceboJazz PharmaceuticalsPhase 2
49
XyremJazz PharmaceuticalsPhase 3
74
JZP258Jazz PharmaceuticalsApproved
82
ADX-N05 + PlaceboJazz PharmaceuticalsPhase 2
49
Xyrem (sodium oxybate) oral solutionJazz PharmaceuticalsPhase 3
74
JZP-258Jazz PharmaceuticalsApproved
82
JZP441 + Matching PlaceboJazz PharmaceuticalsPhase 1
30
Xyrem + Xyrem Placebo + Modafinil at established dose + Modafinil (Placebo)Jazz PharmaceuticalsPhase 3
74
JZP-110 + Placebo oral tabletJazz PharmaceuticalsPhase 3
74
JZP-258Jazz PharmaceuticalsPhase 3
74
Transition from Xyrem to XywavJazz PharmaceuticalsPre-clinical
20
JZP-110Jazz PharmaceuticalsPhase 3
74
Sunosi (solriamfetol) + Other prescription wake-promoting medications or stimulantsAxsome TherapeuticsPre-clinical
20
AXS-12 (reboxetine) + PlaceboAxsome TherapeuticsPhase 3
74
AXS-12 (Reboxetine) + PlaceboAxsome TherapeuticsPhase 2
49
AXS-12 (reboxetine) + PlaceboAxsome TherapeuticsPhase 3
74

Other Products from Axsome Therapeutics

Solriamfetol + PlaceboApproved
82
Solriamfetol 75 MGApproved
82
AXS-05 + BupropionApproved
82
Solriamfetol Oral Tablet + PlaceboApproved
82
AXS-05 (dextromethorphan and bupropion) oral tabletsPhase 3
74